Publication | Open Access
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types
48
Citations
43
References
2017
Year
NCT03018405, EudraCT 2016-003312-12; Pre-result.
| Year | Citations | |
|---|---|---|
Page 1
Page 1